Article citationsMore >>

Aldyab M, Ells PF, Bui R, Chapman TD, Lee H. Kratom-Induced Cholestatic Liver Injury Mimicking Anti-Mitochondrial Antibody-Negative Primary Biliary Cholangitis: A Case Report and Review of Literature. Gastroenterology Res. 2019; 12(4): 211-215.

has been cited by the following article:

Article

Kratom Associated Withdrawal Symptoms and Naltrexone: A Case Report

1Pensacola Regional Campus, Florida State University College of Medicine, Pensacola, United States of America

2Department of Emergency Medicine, Baptist Hospital, Pensacola, United States of America


American Journal of Medical Case Reports. 2022, Vol. 10 No. 9, 214-217
DOI: 10.12691/ajmcr-10-9-1
Copyright © 2022 Science and Education Publishing

Cite this paper:
Reece Vesperman, Shalinee Wayland, Shemar Crawford, Corinne Jackson. Kratom Associated Withdrawal Symptoms and Naltrexone: A Case Report. American Journal of Medical Case Reports. 2022; 10(9):214-217. doi: 10.12691/ajmcr-10-9-1.

Correspondence to: Reece  Vesperman, Pensacola Regional Campus, Florida State University College of Medicine, Pensacola, United States of America. Email: peacevesman@gmail.com

Abstract

Kratom (Mitragyna speciosa Korth), an indigenous herb of Southeast Asia, is popularly used to treat withdrawal symptoms associated with opiate addiction and a myriad of ailments including chronic pain, anxiety and hypertension. Its use has significantly increased in western countries because of its widespread advertisement on the internet as a safe, nonaddictive alternative treatment of pain and opioid dependent disorders. This report describes the first emergency case of toxic encephalopathy, rhabdomyolysis, and liver injury in relation to kratom withdrawal syndrome induced by naltrexone in a 49-year old male. The symptoms were resolved with a regimen of dexmedetomidine, lorazepam, oral lactulose, and a bicarbonate drip. Outpatient treatment with lorazepam and tramadol was recommended for further withdrawal symptoms.

Keywords